Security key
75974E103
OnKure Therapeutics, Inc. - Common Stock, $0.0001 Par Value (RPHM)
CUSIP: 75974E103
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.0001 Par Value
- Total 13F shares
- 228
- Total 13F value
- $389
- Share change
- +228
- SEC-reported price per share
- $1.71
- Number of holders
- 1
- Value change
- +$389
- Number of buys
- 1
- Shares outstanding
- 41,305,653
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
1
Top holders
0
RPHM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q1 2025
OnKure Therapeutics, Inc. SEC filings
OnKure Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75974E103
Recent filing periods:
Ownership snapshot
Top reported holders of RPHM - OnKure Therapeutics, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ACORN BIOVENTURES, L.P.
Disclosed value leader
ACORN BIOVENTURES, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2025
3/4/5
13D/G
13F
Lead comparable stake: 22%
13D/G row: ACORN BIOVENTURES, L.P.
Showing 1-6 of 15 holder rows.
Quick read
ACORN BIOVENTURES, L.P. leads the comparable SEC ownership view at 22%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ACORN BIOVENTURES, L.P.'s linked filing trail.
Comparable ownership
Top 5
ACORN BIOVENTURES, L.P.
22%
Shay Capital LLC
6.3%
CANTOR FITZGERALD & CO.
5.2%
Deep Track Capital, LP
4.1%
Invest A/s Lundbeckfond
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. |
3/4/5
13D/G
10%+ Owner · Anders Hove
|
22%
from 13D/G
|
$9,098,765
4,279,348 shares
mixed-class rows
|
— | 15 May 2025 |
| Shay Capital LLC |
13D/G
13F
Company
|
6.3%
|
$2,057,944
810,214 shares
|
$0 | 15 May 2025 |
| CANTOR FITZGERALD & CO. |
13D/G
Cantor Fitzgerald Securities
|
5.2%
|
$1,606,894
669,539 shares
|
$0 | 30 Jun 2025 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
4.1%
|
$1,330,932
523,989 shares
|
$0 | 31 Dec 2024 |
| Invest A/s Lundbeckfond |
13D/G
Lundbeckfond Invest A/S
|
1.6%
|
$515,930
203,122 shares
|
$0 | 31 Dec 2024 |
| RiverVest Venture Fund III, L.P. |
13D/G
John P. McKearn, Ph.D.
|
1.6%
|
$333,517
196,198 shares
|
$0 | 16 Jan 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
228
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q1 2025 Across Filers
Q1 2025 holders
0
Q3 2025 holders
1
Holder diff
1
| Investor | Q1 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend